OR WAIT null SECS
February 23, 2018
The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
February 22, 2018
The new training center, the Jefferson Institute for Bioprocessing, will prepare engineering students and industry professionals for the field of biologics manufacturing.
Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.
February 21, 2018
The companies have partnered to develop and commercialize vectorized antibodies against tau for Alzheimer's and other neurodegenerative diseases.
February 20, 2018
The company has entered into an agreement with an undisclosed partner to support the development and manufacture of a new biomanufacturing cell line.
February 09, 2018
The companies will partner to further immuno-oncology research using humanized mice.
February 07, 2018
Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.
February 06, 2018
Amgen plans to invest approximately $300 million in a new biomanufacturing plant in the United States.
February 02, 2018
Shire will receive exclusive license to develop and commercialize AB Biosciences' pan receptor interacting molecule program for autoimmune and inflammatory diseases.
January 30, 2018
The acquisition will strengthen Sanofi's R&D strategy and expands its franchise for rare blood disorders.